Clinical trial
Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected…
NCT00463086 · University of Cape Town, Other · Completed
Key facts
| NCT number | NCT00463086 |
|---|---|
| Title | Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons |
| Official title | A Randomized-controlled Trial of Isoniazid Plus Highly Active Antiretroviral Therapy Against Placebo to Prevent Tuberculosis in HIV-infected Persons |
| Acronym | HAART-IPT |
| Lead sponsor | University of Cape Town, Other |
| Collaborators | Medecins Sans Frontieres, Netherlands Imperial College London Johns Hopkins University London School of Hygiene and Tropical Medicine |
| Status | Completed |
| Study type | Interventional |
| Conditions | Tuberculosis, Latent Tuberculosis Infection, HIV Infections |
| Intervention type | Drug |
| Interventions | isoniazid, Placebo |
| Enrollment | 1,368 |
| Start date | Nov 1, 2007 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Apr 20, 2007 |
| Last update posted | Jul 17, 2012 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: